- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Pseudorabies Virus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Pseudorabies Virus Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Government Tender accounting for % of the Pseudorabies Virus Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Inactivated Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pseudorabies Virus Vaccine include Merck, Merial Limited, Boehringer Ingelheim Animal Health (USA) Co., Ltd., Zoetis, and Hipra, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pseudorabies Virus Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Inactivated Vaccine
Naturally Deficient Attenuated Vaccine
Genetic Engineering Vaccine
Market segment by Application can be divided into
Government Tender
Market Sales
The key market players for global Pseudorabies Virus Vaccine market are listed below:
Merck
Merial Limited
Boehringer Ingelheim Animal Health (USA) Co., Ltd.
Zoetis
Hipra
Anhui Divinity Biological Products
Wuhan Keqian Biological Co., Ltd.
China Biotechnology Co., Ltd.
CHINA ANIMAL HUSBANDRY INDUSTRY
Sichuan Huashen
Haley
Tianbang
Dabei Nong
Harvey
Preh Bio
Jiangsu Nannong High-Tech Co.
Guangxi Liyuan Biological Co., Ltd.
Jilin Zhengye Bioengineering Group
Jilin Heyuan Biological Engineering Co., Ltd.
Huapai Biological Engineering Group Co., Ltd.
Beijing Xinde Weite Technology Co., Ltd.
Beijing Veterinary Biopharmaceutical Factory
Qilu Animal Health Products Co., Ltd.
Shanxi Longkel Bio-Pharmaceutical Co., Ltd.
Yunnan Biopharmaceutical Co.
Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd.
Liaoning Yikang Biological Co., Ltd.
Shanghui Huahong Biological Engineering Co., Ltd.
Sichuan Hailinge Biological Pharmaceutical Co., Ltd.
Guangdong Yongshun Biological Pharmaceutical Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pseudorabies Virus Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pseudorabies Virus Vaccine, with price, sales, revenue and global market share of Pseudorabies Virus Vaccine from 2019 to 2022.
Chapter 3, the Pseudorabies Virus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pseudorabies Virus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pseudorabies Virus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pseudorabies Virus Vaccine.
Chapter 13, 14, and 15, to describe Pseudorabies Virus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Pseudorabies Virus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pseudorabies Virus Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Inactivated Vaccine
1.2.3 Naturally Deficient Attenuated Vaccine
1.2.4 Genetic Engineering Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Pseudorabies Virus Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Pseudorabies Virus Vaccine Market Size & Forecast
1.4.1 Global Pseudorabies Virus Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pseudorabies Virus Vaccine Sales in Volume (2017-2028)
1.4.3 Global Pseudorabies Virus Vaccine Price (2017-2028)
1.5 Global Pseudorabies Virus Vaccine Production Capacity Analysis
1.5.1 Global Pseudorabies Virus Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Pseudorabies Virus Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pseudorabies Virus Vaccine Market Drivers
1.6.2 Pseudorabies Virus Vaccine Market Restraints
1.6.3 Pseudorabies Virus Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Pseudorabies Virus Vaccine Product and Services
2.1.4 Merck Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merial Limited
2.2.1 Merial Limited Details
2.2.2 Merial Limited Major Business
2.2.3 Merial Limited Pseudorabies Virus Vaccine Product and Services
2.2.4 Merial Limited Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Boehringer Ingelheim Animal Health (USA) Co., Ltd.
2.3.1 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Details
2.3.2 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Major Business
2.3.3 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.3.4 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Zoetis
2.4.1 Zoetis Details
2.4.2 Zoetis Major Business
2.4.3 Zoetis Pseudorabies Virus Vaccine Product and Services
2.4.4 Zoetis Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Hipra
2.5.1 Hipra Details
2.5.2 Hipra Major Business
2.5.3 Hipra Pseudorabies Virus Vaccine Product and Services
2.5.4 Hipra Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Anhui Divinity Biological Products
2.6.1 Anhui Divinity Biological Products Details
2.6.2 Anhui Divinity Biological Products Major Business
2.6.3 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Product and Services
2.6.4 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Wuhan Keqian Biological Co., Ltd.
2.7.1 Wuhan Keqian Biological Co., Ltd. Details
2.7.2 Wuhan Keqian Biological Co., Ltd. Major Business
2.7.3 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.7.4 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 China Biotechnology Co., Ltd.
2.8.1 China Biotechnology Co., Ltd. Details
2.8.2 China Biotechnology Co., Ltd. Major Business
2.8.3 China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.8.4 China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 CHINA ANIMAL HUSBANDRY INDUSTRY
2.9.1 CHINA ANIMAL HUSBANDRY INDUSTRY Details
2.9.2 CHINA ANIMAL HUSBANDRY INDUSTRY Major Business
2.9.3 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Product and Services
2.9.4 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Sichuan Huashen
2.10.1 Sichuan Huashen Details
2.10.2 Sichuan Huashen Major Business
2.10.3 Sichuan Huashen Pseudorabies Virus Vaccine Product and Services
2.10.4 Sichuan Huashen Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Haley
2.11.1 Haley Details
2.11.2 Haley Major Business
2.11.3 Haley Pseudorabies Virus Vaccine Product and Services
2.11.4 Haley Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Tianbang
2.12.1 Tianbang Details
2.12.2 Tianbang Major Business
2.12.3 Tianbang Pseudorabies Virus Vaccine Product and Services
2.12.4 Tianbang Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Dabei Nong
2.13.1 Dabei Nong Details
2.13.2 Dabei Nong Major Business
2.13.3 Dabei Nong Pseudorabies Virus Vaccine Product and Services
2.13.4 Dabei Nong Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Harvey
2.14.1 Harvey Details
2.14.2 Harvey Major Business
2.14.3 Harvey Pseudorabies Virus Vaccine Product and Services
2.14.4 Harvey Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Preh Bio
2.15.1 Preh Bio Details
2.15.2 Preh Bio Major Business
2.15.3 Preh Bio Pseudorabies Virus Vaccine Product and Services
2.15.4 Preh Bio Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Jiangsu Nannong High-Tech Co.
2.16.1 Jiangsu Nannong High-Tech Co. Details
2.16.2 Jiangsu Nannong High-Tech Co. Major Business
2.16.3 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Product and Services
2.16.4 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Guangxi Liyuan Biological Co., Ltd.
2.17.1 Guangxi Liyuan Biological Co., Ltd. Details
2.17.2 Guangxi Liyuan Biological Co., Ltd. Major Business
2.17.3 Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.17.4 Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Jilin Zhengye Bioengineering Group
2.18.1 Jilin Zhengye Bioengineering Group Details
2.18.2 Jilin Zhengye Bioengineering Group Major Business
2.18.3 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Product and Services
2.18.4 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Jilin Heyuan Biological Engineering Co., Ltd.
2.19.1 Jilin Heyuan Biological Engineering Co., Ltd. Details
2.19.2 Jilin Heyuan Biological Engineering Co., Ltd. Major Business
2.19.3 Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.19.4 Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Huapai Biological Engineering Group Co., Ltd.
2.20.1 Huapai Biological Engineering Group Co., Ltd. Details
2.20.2 Huapai Biological Engineering Group Co., Ltd. Major Business
2.20.3 Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.20.4 Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Beijing Xinde Weite Technology Co., Ltd.
2.21.1 Beijing Xinde Weite Technology Co., Ltd. Details
2.21.2 Beijing Xinde Weite Technology Co., Ltd. Major Business
2.21.3 Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.21.4 Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Beijing Veterinary Biopharmaceutical Factory
2.22.1 Beijing Veterinary Biopharmaceutical Factory Details
2.22.2 Beijing Veterinary Biopharmaceutical Factory Major Business
2.22.3 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Product and Services
2.22.4 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 Qilu Animal Health Products Co., Ltd.
2.23.1 Qilu Animal Health Products Co., Ltd. Details
2.23.2 Qilu Animal Health Products Co., Ltd. Major Business
2.23.3 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.23.4 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24 Shanxi Longkel Bio-Pharmaceutical Co., Ltd.
2.24.1 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Details
2.24.2 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Major Business
2.24.3 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.24.4 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.25 Yunnan Biopharmaceutical Co.
2.25.1 Yunnan Biopharmaceutical Co. Details
2.25.2 Yunnan Biopharmaceutical Co. Major Business
2.25.3 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Product and Services
2.25.4 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.26 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd.
2.26.1 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Details
2.26.2 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Major Business
2.26.3 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.26.4 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.27 Liaoning Yikang Biological Co., Ltd.
2.27.1 Liaoning Yikang Biological Co., Ltd. Details
2.27.2 Liaoning Yikang Biological Co., Ltd. Major Business
2.27.3 Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.27.4 Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.28 Shanghui Huahong Biological Engineering Co., Ltd.
2.28.1 Shanghui Huahong Biological Engineering Co., Ltd. Details
2.28.2 Shanghui Huahong Biological Engineering Co., Ltd. Major Business
2.28.3 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.28.4 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.29 Sichuan Hailinge Biological Pharmaceutical Co., Ltd.
2.29.1 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Details
2.29.2 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Major Business
2.29.3 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.29.4 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.30 Guangdong Yongshun Biological Pharmaceutical Co., Ltd.
2.30.1 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Details
2.30.2 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Major Business
2.30.3 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product and Services
2.30.4 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pseudorabies Virus Vaccine Breakdown Data by Manufacturer
3.1 Global Pseudorabies Virus Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pseudorabies Virus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pseudorabies Virus Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Pseudorabies Virus Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Pseudorabies Virus Vaccine Manufacturer Market Share in 2021
3.5 Global Pseudorabies Virus Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pseudorabies Virus Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pseudorabies Virus Vaccine Market Size by Region
4.1.1 Global Pseudorabies Virus Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Pseudorabies Virus Vaccine Revenue by Region (2017-2028)
4.2 North America Pseudorabies Virus Vaccine Revenue (2017-2028)
4.3 Europe Pseudorabies Virus Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Pseudorabies Virus Vaccine Revenue (2017-2028)
4.5 South America Pseudorabies Virus Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Pseudorabies Virus Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pseudorabies Virus Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Pseudorabies Virus Vaccine Revenue by Type (2017-2028)
5.3 Global Pseudorabies Virus Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Pseudorabies Virus Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Pseudorabies Virus Vaccine Revenue by Application (2017-2028)
6.3 Global Pseudorabies Virus Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Pseudorabies Virus Vaccine Sales by Type (2017-2028)
7.2 North America Pseudorabies Virus Vaccine Sales by Application (2017-2028)
7.3 North America Pseudorabies Virus Vaccine Market Size by Country
7.3.1 North America Pseudorabies Virus Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Pseudorabies Virus Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Pseudorabies Virus Vaccine Sales by Type (2017-2028)
8.2 Europe Pseudorabies Virus Vaccine Sales by Application (2017-2028)
8.3 Europe Pseudorabies Virus Vaccine Market Size by Country
8.3.1 Europe Pseudorabies Virus Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Pseudorabies Virus Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pseudorabies Virus Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Pseudorabies Virus Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Pseudorabies Virus Vaccine Market Size by Region
9.3.1 Asia-Pacific Pseudorabies Virus Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pseudorabies Virus Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Pseudorabies Virus Vaccine Sales by Type (2017-2028)
10.2 South America Pseudorabies Virus Vaccine Sales by Application (2017-2028)
10.3 South America Pseudorabies Virus Vaccine Market Size by Country
10.3.1 South America Pseudorabies Virus Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Pseudorabies Virus Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pseudorabies Virus Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Pseudorabies Virus Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Pseudorabies Virus Vaccine Market Size by Country
11.3.1 Middle East & Africa Pseudorabies Virus Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pseudorabies Virus Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pseudorabies Virus Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pseudorabies Virus Vaccine
12.3 Pseudorabies Virus Vaccine Production Process
12.4 Pseudorabies Virus Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pseudorabies Virus Vaccine Typical Distributors
13.3 Pseudorabies Virus Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Pseudorabies Virus Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Pseudorabies Virus Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Pseudorabies Virus Vaccine Product and Services
Table 6. Merck Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merial Limited Basic Information, Manufacturing Base and Competitors
Table 8. Merial Limited Major Business
Table 9. Merial Limited Pseudorabies Virus Vaccine Product and Services
Table 10. Merial Limited Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 12. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Major Business
Table 13. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 14. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Zoetis Basic Information, Manufacturing Base and Competitors
Table 16. Zoetis Major Business
Table 17. Zoetis Pseudorabies Virus Vaccine Product and Services
Table 18. Zoetis Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Hipra Basic Information, Manufacturing Base and Competitors
Table 20. Hipra Major Business
Table 21. Hipra Pseudorabies Virus Vaccine Product and Services
Table 22. Hipra Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Anhui Divinity Biological Products Basic Information, Manufacturing Base and Competitors
Table 24. Anhui Divinity Biological Products Major Business
Table 25. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Product and Services
Table 26. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Wuhan Keqian Biological Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 28. Wuhan Keqian Biological Co., Ltd. Major Business
Table 29. Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 30. Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. China Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 32. China Biotechnology Co., Ltd. Major Business
Table 33. China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 34. China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. CHINA ANIMAL HUSBANDRY INDUSTRY Basic Information, Manufacturing Base and Competitors
Table 36. CHINA ANIMAL HUSBANDRY INDUSTRY Major Business
Table 37. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Product and Services
Table 38. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Sichuan Huashen Basic Information, Manufacturing Base and Competitors
Table 40. Sichuan Huashen Major Business
Table 41. Sichuan Huashen Pseudorabies Virus Vaccine Product and Services
Table 42. Sichuan Huashen Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Haley Basic Information, Manufacturing Base and Competitors
Table 44. Haley Major Business
Table 45. Haley Pseudorabies Virus Vaccine Product and Services
Table 46. Haley Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Tianbang Basic Information, Manufacturing Base and Competitors
Table 48. Tianbang Major Business
Table 49. Tianbang Pseudorabies Virus Vaccine Product and Services
Table 50. Tianbang Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Dabei Nong Basic Information, Manufacturing Base and Competitors
Table 52. Dabei Nong Major Business
Table 53. Dabei Nong Pseudorabies Virus Vaccine Product and Services
Table 54. Dabei Nong Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Harvey Basic Information, Manufacturing Base and Competitors
Table 56. Harvey Major Business
Table 57. Harvey Pseudorabies Virus Vaccine Product and Services
Table 58. Harvey Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Preh Bio Basic Information, Manufacturing Base and Competitors
Table 60. Preh Bio Major Business
Table 61. Preh Bio Pseudorabies Virus Vaccine Product and Services
Table 62. Preh Bio Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Jiangsu Nannong High-Tech Co. Basic Information, Manufacturing Base and Competitors
Table 64. Jiangsu Nannong High-Tech Co. Major Business
Table 65. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Product and Services
Table 66. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Guangxi Liyuan Biological Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 68. Guangxi Liyuan Biological Co., Ltd. Major Business
Table 69. Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 70. Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Jilin Zhengye Bioengineering Group Basic Information, Manufacturing Base and Competitors
Table 72. Jilin Zhengye Bioengineering Group Major Business
Table 73. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Product and Services
Table 74. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Jilin Heyuan Biological Engineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 76. Jilin Heyuan Biological Engineering Co., Ltd. Major Business
Table 77. Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 78. Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Huapai Biological Engineering Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 80. Huapai Biological Engineering Group Co., Ltd. Major Business
Table 81. Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 82. Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Beijing Xinde Weite Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 84. Beijing Xinde Weite Technology Co., Ltd. Major Business
Table 85. Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 86. Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. Beijing Veterinary Biopharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 88. Beijing Veterinary Biopharmaceutical Factory Major Business
Table 89. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Product and Services
Table 90. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Qilu Animal Health Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 92. Qilu Animal Health Products Co., Ltd. Major Business
Table 93. Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 94. Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 95. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 96. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Major Business
Table 97. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 98. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 99. Yunnan Biopharmaceutical Co. Basic Information, Manufacturing Base and Competitors
Table 100. Yunnan Biopharmaceutical Co. Major Business
Table 101. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Product and Services
Table 102. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 103. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 104. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Major Business
Table 105. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 106. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 107. Liaoning Yikang Biological Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 108. Liaoning Yikang Biological Co., Ltd. Major Business
Table 109. Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 110. Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 111. Shanghui Huahong Biological Engineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 112. Shanghui Huahong Biological Engineering Co., Ltd. Major Business
Table 113. Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 114. Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 115. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 116. Sichuan Hailinge Biological Pharmaceutical Co., Ltd.Major Business
Table 117. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 118. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 119. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 120. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Major Business
Table 121. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product and Services
Table 122. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 123. Global Pseudorabies Virus Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Doses)
Table 124. Global Pseudorabies Virus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 125. Market Position of Manufacturers in Pseudorabies Virus Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 126. Global Pseudorabies Virus Vaccine Production Capacity by Company, (M Doses): 2020 VS 2021
Table 127. Head Office and Pseudorabies Virus Vaccine Production Site of Key Manufacturer
Table 128. Pseudorabies Virus Vaccine New Entrant and Capacity Expansion Plans
Table 129. Pseudorabies Virus Vaccine Mergers & Acquisitions in the Past Five Years
Table 130. Global Pseudorabies Virus Vaccine Sales by Region (2017-2022) & (M Doses)
Table 131. Global Pseudorabies Virus Vaccine Sales by Region (2023-2028) & (M Doses)
Table 132. Global Pseudorabies Virus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 133. Global Pseudorabies Virus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 134. Global Pseudorabies Virus Vaccine Sales by Type (2017-2022) & (M Doses)
Table 135. Global Pseudorabies Virus Vaccine Sales by Type (2023-2028) & (M Doses)
Table 136. Global Pseudorabies Virus Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 137. Global Pseudorabies Virus Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 138. Global Pseudorabies Virus Vaccine Price by Type (2017-2022) & (USD/Doses)
Table 139. Global Pseudorabies Virus Vaccine Price by Type (2023-2028) & (USD/Doses)
Table 140. Global Pseudorabies Virus Vaccine Sales by Application (2017-2022) & (M Doses)
Table 141. Global Pseudorabies Virus Vaccine Sales by Application (2023-2028) & (M Doses)
Table 142. Global Pseudorabies Virus Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 143. Global Pseudorabies Virus Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 144. Global Pseudorabies Virus Vaccine Price by Application (2017-2022) & (USD/Doses)
Table 145. Global Pseudorabies Virus Vaccine Price by Application (2023-2028) & (USD/Doses)
Table 146. North America Pseudorabies Virus Vaccine Sales by Country (2017-2022) & (M Doses)
Table 147. North America Pseudorabies Virus Vaccine Sales by Country (2023-2028) & (M Doses)
Table 148. North America Pseudorabies Virus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 149. North America Pseudorabies Virus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 150. North America Pseudorabies Virus Vaccine Sales by Type (2017-2022) & (M Doses)
Table 151. North America Pseudorabies Virus Vaccine Sales by Type (2023-2028) & (M Doses)
Table 152. North America Pseudorabies Virus Vaccine Sales by Application (2017-2022) & (M Doses)
Table 153. North America Pseudorabies Virus Vaccine Sales by Application (2023-2028) & (M Doses)
Table 154. Europe Pseudorabies Virus Vaccine Sales by Country (2017-2022) & (M Doses)
Table 155. Europe Pseudorabies Virus Vaccine Sales by Country (2023-2028) & (M Doses)
Table 156. Europe Pseudorabies Virus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 157. Europe Pseudorabies Virus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 158. Europe Pseudorabies Virus Vaccine Sales by Type (2017-2022) & (M Doses)
Table 159. Europe Pseudorabies Virus Vaccine Sales by Type (2023-2028) & (M Doses)
Table 160. Europe Pseudorabies Virus Vaccine Sales by Application (2017-2022) & (M Doses)
Table 161. Europe Pseudorabies Virus Vaccine Sales by Application (2023-2028) & (M Doses)
Table 162. Asia-Pacific Pseudorabies Virus Vaccine Sales by Region (2017-2022) & (M Doses)
Table 163. Asia-Pacific Pseudorabies Virus Vaccine Sales by Region (2023-2028) & (M Doses)
Table 164. Asia-Pacific Pseudorabies Virus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 165. Asia-Pacific Pseudorabies Virus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 166. Asia-Pacific Pseudorabies Virus Vaccine Sales by Type (2017-2022) & (M Doses)
Table 167. Asia-Pacific Pseudorabies Virus Vaccine Sales by Type (2023-2028) & (M Doses)
Table 168. Asia-Pacific Pseudorabies Virus Vaccine Sales by Application (2017-2022) & (M Doses)
Table 169. Asia-Pacific Pseudorabies Virus Vaccine Sales by Application (2023-2028) & (M Doses)
Table 170. South America Pseudorabies Virus Vaccine Sales by Country (2017-2022) & (M Doses)
Table 171. South America Pseudorabies Virus Vaccine Sales by Country (2023-2028) & (M Doses)
Table 172. South America Pseudorabies Virus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 173. South America Pseudorabies Virus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 174. South America Pseudorabies Virus Vaccine Sales by Type (2017-2022) & (M Doses)
Table 175. South America Pseudorabies Virus Vaccine Sales by Type (2023-2028) & (M Doses)
Table 176. South America Pseudorabies Virus Vaccine Sales by Application (2017-2022) & (M Doses)
Table 177. South America Pseudorabies Virus Vaccine Sales by Application (2023-2028) & (M Doses)
Table 178. Middle East & Africa Pseudorabies Virus Vaccine Sales by Region (2017-2022) & (M Doses)
Table 179. Middle East & Africa Pseudorabies Virus Vaccine Sales by Region (2023-2028) & (M Doses)
Table 180. Middle East & Africa Pseudorabies Virus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 181. Middle East & Africa Pseudorabies Virus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 182. Middle East & Africa Pseudorabies Virus Vaccine Sales by Type (2017-2022) & (M Doses)
Table 183. Middle East & Africa Pseudorabies Virus Vaccine Sales by Type (2023-2028) & (M Doses)
Table 184. Middle East & Africa Pseudorabies Virus Vaccine Sales by Application (2017-2022) & (M Doses)
Table 185. Middle East & Africa Pseudorabies Virus Vaccine Sales by Application (2023-2028) & (M Doses)
Table 186. Pseudorabies Virus Vaccine Raw Material
Table 187. Key Manufacturers of Pseudorabies Virus Vaccine Raw Materials
Table 188. Direct Channel Pros & Cons
Table 189. Indirect Channel Pros & Cons
Table 190. Pseudorabies Virus Vaccine Typical Distributors
Table 191. Pseudorabies Virus Vaccine Typical Customers
List of Figures
Figure 1. Pseudorabies Virus Vaccine Picture
Figure 2. Global Pseudorabies Virus Vaccine Revenue Market Share by Type in 2021
Figure 3. Inactivated Vaccine
Figure 4. Naturally Deficient Attenuated Vaccine
Figure 5. Genetic Engineering Vaccine
Figure 6. Global Pseudorabies Virus Vaccine Revenue Market Share by Application in 2021
Figure 7. Government Tender
Figure 8. Market Sales
Figure 9. Global Pseudorabies Virus Vaccine Revenue, (USD Million) & (M Doses): 2017 & 2021 & 2028
Figure 10. Global Pseudorabies Virus Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Pseudorabies Virus Vaccine Sales (2017-2028) & (M Doses)
Figure 12. Global Pseudorabies Virus Vaccine Price (2017-2028) & (USD/Doses)
Figure 13. Global Pseudorabies Virus Vaccine Production Capacity (2017-2028) & (M Doses)
Figure 14. Global Pseudorabies Virus Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Pseudorabies Virus Vaccine Market Drivers
Figure 16. Pseudorabies Virus Vaccine Market Restraints
Figure 17. Pseudorabies Virus Vaccine Market Trends
Figure 18. Global Pseudorabies Virus Vaccine Sales Market Share by Manufacturer in 2021
Figure 19. Global Pseudorabies Virus Vaccine Revenue Market Share by Manufacturer in 2021
Figure 20. Pseudorabies Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Pseudorabies Virus Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Pseudorabies Virus Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Pseudorabies Virus Vaccine Sales Market Share by Region (2017-2028)
Figure 24. Global Pseudorabies Virus Vaccine Revenue Market Share by Region (2017-2028)
Figure 25. North America Pseudorabies Virus Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Pseudorabies Virus Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Pseudorabies Virus Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. South America Pseudorabies Virus Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Pseudorabies Virus Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Global Pseudorabies Virus Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global Pseudorabies Virus Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global Pseudorabies Virus Vaccine Price by Type (2017-2028) & (USD/Doses)
Figure 33. Global Pseudorabies Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 34. Global Pseudorabies Virus Vaccine Revenue Market Share by Application (2017-2028)
Figure 35. Global Pseudorabies Virus Vaccine Price by Application (2017-2028) & (USD/Doses)
Figure 36. North America Pseudorabies Virus Vaccine Sales Market Share by Type (2017-2028)
Figure 37. North America Pseudorabies Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 38. North America Pseudorabies Virus Vaccine Sales Market Share by Country (2017-2028)
Figure 39. North America Pseudorabies Virus Vaccine Revenue Market Share by Country (2017-2028)
Figure 40. United States Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Pseudorabies Virus Vaccine Sales Market Share by Type (2017-2028)
Figure 44. Europe Pseudorabies Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe Pseudorabies Virus Vaccine Sales Market Share by Country (2017-2028)
Figure 46. Europe Pseudorabies Virus Vaccine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Pseudorabies Virus Vaccine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Pseudorabies Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Pseudorabies Virus Vaccine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Pseudorabies Virus Vaccine Revenue Market Share by Region (2017-2028)
Figure 56. China Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Pseudorabies Virus Vaccine Sales Market Share by Type (2017-2028)
Figure 63. South America Pseudorabies Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 64. South America Pseudorabies Virus Vaccine Sales Market Share by Country (2017-2028)
Figure 65. South America Pseudorabies Virus Vaccine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Pseudorabies Virus Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Pseudorabies Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Pseudorabies Virus Vaccine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Pseudorabies Virus Vaccine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Pseudorabies Virus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Pseudorabies Virus Vaccine in 2021
Figure 77. Manufacturing Process Analysis of Pseudorabies Virus Vaccine
Figure 78. Pseudorabies Virus Vaccine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
